Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > 💡A better Buy ~ SHRM Champignon Brands🔋🍄🌪
View:
Comment by CyberSecurity on Apr 23, 2021 3:07pm
Good Call. Overvalued, will plumet. All because of Nasdaq listing, c'mon folks. People are sleeping on SHRM today, that's fine wait until substantial day-by-day news and they will be scrounging for $3 there also.
Comment by noeIstrlfe on Apr 23, 2021 3:34pm
Was thinking same thing. Sold today half my MMED for SHRM. I'd rather be holding a company with better finances as well not succumb to Canaccords manipulation ... They are going to dump heavy probably now even before $1
Comment by Covid19 on Apr 27, 2021 4:23pm
The stress of the COVID-19 pandemic has been unprecedented, and it has highlighted the need to provide novel treatments for individuals suffering from depression. We are well positioned to be a leader in both implementing rapid-acting ketamine/esketamine-based treatments for depression and discovering innovative future treatments for persons affected by depression." "We are pleased to be ...more  
Comment by DogeCoin on Apr 28, 2021 12:57am
Burned on MMED sleeping.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities